Info

social, health, political imagery through the lens of George J Huba PhD © 2012-2019

Want to get the attention of Big Pharma and patients who do not try to prevent common diseases? Require this statement or something equivalent on every bottle of medications (prescription and not prescription) sold. [Of course, filling in the blanks with numbers derived from clinical trials, longitudinal studies and other credible scientific information collected by independent qualified professionals.]

This drug works ___% of the time for ___% of the patients who use it, producing a ___% percent improvement for ___ months at a list price of $___ per month. Insurance typically pays for ___% of the cost. ___% of patients experience severe side effects.

This data — or some variation of it — is currently or should be collected by the FDA and confirmed by consultants independent of both the FDA and the pharmaceutical company.

Big Pharma will not like this proposal. Elected officials who have been “bought” by Big Pharma contributions to their election funds will not like this proposal. We should listen to neither group.

Consumers of medicines and treatments should know the approximate cost of their treatment and its efficacy when collaborating with their healthcare providers on a treatment plan.

Everyone should consider the relative costs of preventing diseases rather than treating them. The information provided by these labels could help individuals decide whether a healthy lifestyle provides financial benefits to them.

Comments

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Basic HTML is allowed. Your email address will not be published.

Subscribe to this comment feed via RSS